According to Adial Pharmaceuticals 's latest financial reports the company's current earnings (TTM) are -$8.64 M. In 2022 the company made an earning of -$11.57 M an increase over its 2021 earnings that were of -$19.52 M.The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2023 (TTM) | -$8.64 M | -25.36% |
2022 | -$11.57 M | -40.76% |
2021 | -$19.52 M | 79.17% |
2020 | -$10.9 M | 26.79% |
2019 | -$8.6 M | -26.14% |
2018 | -$11.64 M | 920.78% |
2017 | -$1.14 M |
Company | Earnings | Earnings differencediff. | Country |
---|---|---|---|
Nymox Pharmaceutical NYMX | -$2.17 M | -74.96% | Bahamas |
NRC Health
NRC | $40.82 M | -573.00% | ๐บ๐ธ USA |